An international team of researchers from the United States and Australia has made a successful vaccine formulation that targets pathological proteins associated with Alzheimer’s disease. In AD, changes in tau protein lead to the disintegration of microtubules in brain cells. Image credit: Alzheimer’s Disease Education and Referral Center / National Institute on Aging. Alzheimer’s disease (AD) is the most common cause of dementia, and worldwide...
